BRUNO QUESNEL

Professor, Head of the Leukemia and MDS department

Centre Hospitalier Régional Universitaire de Lille

France

Research Interests

Explore related searches

Professors in France Professors in Immunology Immunology professors in France

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Bruno Quesnel is a Professor and Head of the Leukemia and MDS department at Centre Hospitalier Régional et Universitaire de Lille, France. His research primarily focuses on leukemia, specifically the metabolism of leukemic cells and the mechanisms underlying resistance to treatment. Recent publications include studies on RNA-Seq analyses of B cells, metabolic pathways in leukemic persistence, and innovative approaches to enhance immune responses against tumors.

Articles (13)

Year:

2025

Year:

2024

Year:

2024

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Collaborators (16)

Xavier Thuru

Université de Lille

FRANCE

BRUNO QUESNEL

Research Interests

Explore related searches

Contact this professor

About

Articles (13)

Author Correction: Full-length RNA-Seq of the RHOH gene in human B cells reveals new exons and splicing patterns

Key role of glutamine metabolism in persistence of leukemic cells upon exposition to FLT3 tyrosine kinase inhibitors

Full-length RNA-Seq of the RHOH gene in human B cells reveals new exons and splicing patterns

Successful bridging to cell therapy for relapsed/refractory acute lymphoblastic leukaemia with a combination of venetoclax and PEG‐asparaginase

A randomised phase II study of azacitidine (AZA) alone or with Lenalidomide (LEN), Valproic acid (VPA) or Idarubicin (IDA) in higher‐Risk MDS or low blast AML: GFM's “pick a winner” trial, with the impact of somatic mutations

TRPC3 shapes the ER-mitochondria Ca<sup>2+</sup> transfer characterizing tumour-promoting senescence.

Pyrazolones as inhibitors of immune checkpoint blocking the PD-1/PD-L1 interaction

Drug Repurposing to Enhance Antitumor Response to PD-1/PD-L1 Immune Checkpoint Inhibitors

Involvement of ORAI1/SOCE in Human AML Cell Lines and Primary Cells According to ABCB1 Activity, LSC Compartment and Potential Resistance to Ara-C Exposure

Detection of residual and chemoresistant leukemic cells in an immune-competent mouse model of acute myeloid leukemia: Potential for unravelling their interactions with immunity

Single-agent 5-azacytidine as post-transplant maintenance in high-risk myeloid malignancies undergoing allogeneic hematopoietic cell transplantation

Machine learning identifies the independent role of dysplasia in the prediction of response to chemotherapy in AML

Successful allogeneic hematopoietic stem cell transplantation in patients with VEXAS syndrome: a 2-center experience

Collaborators (16)

Xavier Thuru

Mehmet Çagatay Tarhan

Ingrid Fliniaux

Meyling H. Cheok

David Bernard

Xavier Dezitter

Dimitra Gkika

Martin Figeac

Régis MILLET

Carine Brinster

Jan Parys

Pierre Fenaux

lionel adès

Yasmine TOUIL

PIERRE PETERLIN

jerome kluza

Make your next move.